Metraipolis › archive › dc_cd30a3c9980d

CUL4B promotes hepatocellular carcinoma progression and oxaliplatin resistance by facilitating FUS degradation — Europe PMC PMID:41392287

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41392287
DOI
10.1038/s41419-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-07T16:01:41.144Z
SHA-256 of the archived text
c4e1f8913e6f23f444c96d265c27cc916ae3581a78771f8b43237a07c2aa21bc
Stable URL of this page
https://metraipolis.com/documento/dc_cd30a3c9980d

How to cite

CUL4B promotes hepatocellular carcinoma progression and oxaliplatin resistance by facilitating FUS degradation — Europe PMC PMID:41392287 — Europe PMC (en), https://europepmc.org/article/MED/41392287 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd30a3c9980d (Metraipolis archive dc_cd30a3c9980d, sha256 c4e1f8913e6f23f444c96d265c27cc916ae3581a78771f8b43237a07c2aa21bc)
BibTeX
@misc{dccd30a3c9980d,
  title = {CUL4B promotes hepatocellular carcinoma progression and oxaliplatin resistance by facilitating FUS degradation — Europe PMC PMID:41392287},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41392287},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd30a3c9980d; sha256 c4e1f8913e6f23f444c96d265c27cc916ae3581a78771f8b43237a07c2aa21bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41392287. Agents can read the archived copy with the MCP tool read_document.